Searched for
STRIDES PHARMA STOCKS
Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...- Quant Small Cap Fund exits HDFC Bank, Jio Financial Services and 5 other stocks in AprilQuant Small Cap Fund reshuffled its portfolio in April, exiting seven stocks including HDFC Bank and Jio Financial Services while adding ne...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Stock Radar: Strides Pharma stock hits fresh 52-week high in July; will the rally continue in August?Strides Pharma Science Limited stock shows positive momentum. It broke a one-month consolidation in July 2025. Experts suggest a buy for a ...
- Stock Radar: Strides Pharma breaks out from 7-month consolidation to hit fresh 52-week high; time to buy?Strides Pharma Science stock shows positive movement. It broke a seven-month consolidation phase. Experts suggest a buy with a target of Rs...
- Stock Radar: This pharma stock gave multibagger returns in the last 1 year; should you buy, sell or hold Strides Pharma?Strides Pharma Science Ltd (STAR) surged over 200% in a year, hitting Rs 1,675 in October. After a dip, the stock rebounded from its 20-wee...
- Stock Radar: This pharma stock sees mild consolidation after 130% rally in 1 year; time to buy the dip?The pharma stock is a part of the S&P BSE Smallcap index. It saw an uptrend, rising from Rs 393 as of June 9, 2023, to Rs 901 recorded on J...
- Buy Strides Pharma Science, target price Rs 630: Prabhudas LilladherPromoters held 28.07 per cent stake in the company as of 30-Jun-2023, while FIIs owned 16.72 per cent, DIIs 19.59 per cent.
- Reduce Strides Pharma Science, target price Rs 495: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 4766.18 Crore) operating in Pha...
- Strides Pharma shares fall over 3% on plans to spin off CDMO, gelatin businessesAs per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. T...
- Strides Pharma announces business rejig. Shares end 7% up, hit 52 week highThe announcement was made by the company ahead of the market closing. The stock settled at Rs 536 on the NSE, up Rs 37, or 7% over Friday's...
- Smallcap pharma stock jumps over 11% as arm receives tentative USFDA approval for HIV drug DolutegravirThe company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with the USFDA, of whic...
- Buy Strides Pharma Science, target price Rs 500: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3085.64 Crore) operating in Pha...
- Buy Strides Pharma Science, target price Rs 402: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3026.83 Crore) operating in Pha...
- Accumulate Strides Pharma Science, target price Rs 355: GeojitStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 2836.92 Crore) operating in Pha...
- Strides Pharma Science Q3 net declines 69% to Rs 92 croreThe consolidated income of the company increased to Rs 744.66 crore in the Oct-Dec period.
- Strides Shasun rallies 2% on USFDA drug approvalThe company has 74 cumulative ANDA filings with the USFDA.
- Buy pharma stocks on declines: P Phani Sekhar, Angel BrokingThings have been good for some midcap pharma companies. Although they remained midcap in their classification but revenues have almost star...
- Sun Pharma, Cipla best bet among pharma stocks: Sajiv DhawanMost of the times these stocks will trade in a range. It is not a sector that I say would outperform even in the next year or so.
- Strides Arcolab & Aurobindo Pharma are good stocks to own: Satish BetadpurSatish Betadpur, CFA, Global Research Director, Independent International Investment Research PLC in an interview with ET Now talks about S...
Load More
